Duchenne muscular dystrophy can increase the risk of pressure sores, but practical strategies can help in preventing skin ...
DMD treatment Agamree works differently from traditional corticosteroids, blocking the action of a receptor, a study found.
Serendipitously, columnist Shalom Lim turns 30 on the day of Singapore's Purple Parade, its largest annual disability ...
As a seasoned professional, columnist Patrick Moeschen “muscles through” everyday challenges — despite the irony.
Feeling discouraged by the progression of his FSHD, columnist Robin Stemple focuses on the love and kind gestures he's ...
Brogidirsen shows motor benefits and safety over 3.5 years of treatment in people with DMD who are amenable to exon 44 ...
The Muscular Dystrophy Association's agenda at its 2026 MDA Clinical & Scientific Conference in March will focus on groundbreaking research.
Three boys with DMD given the gene therapy GNT0004 in a trial showed sustained improvements in motor function after two years ...
Health Canada has approved Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in patients ages 4 and older, making Agamree the first approved DMD treatment in Canada. DMD is caused by ...
Columnist Betty Vertin's sons with Duchenne MD have seen their social circle shrink over the years, but they now enjoy time with each other.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback